All articles tagged: Personal history of malignant neoplasm of prostate (Z85.46)


Evalytics 08 April at 08.52 PM Screening with a PSA test has a small impact on prostate cancer deaths but leads to overdiagnosis, finds study A study finds that routine PSA screening for prostate cancer has a small impact on reducing deaths but leads to overdiagnosis and overtreatment. Researchers suggest reconsidering the current approach to prostate cancer screening. They propose individualized screening strategies based on age and risk factors to minimize harms and maximize benefits. 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Evalytics 05 February at 08.48 PM Improving fitness may be linked to a 35% lower risk of prostate cancer, study finds Improving fitness lowers the risk of prostate cancer, according to a study. Higher cardiorespiratory fitness reduces the likelihood of developing prostate cancer, emphasizing the importance of regular exercise for prevention. 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 31 January at 05.04 PM Change in Cardiorespiratory Fitness Linked to Prostate Cancer Incidence Change in cardiorespiratory fitness (CRF) is inversely associated with the risk for prostate cancer incidence, but not mortality, according to a study published online Jan. 30 in the British Journal of Sports Medicine.Kate A. Bolam, Ph.D., from the Swedish School of Sport and Health Sciences GIH in Stockholm, and colleagues conducted 1 Likes 0 Comments 1 Shares Facebook Twitter LinkedIn
HealthDay 26 January at 04.44 PM Digital Rectal Exam Has Low Diagnostic Value for Prostate Cancer Digital rectal examination (DRE) exhibits low diagnostic value as an independent test and supplementary measure to prostate-specific antigen (PSA) for detection of prostate cancer, according to a study published online Jan. 4 in European Urology Oncology.Akihiro Matsukawa, from the Medical University of Vienna in Austria, and colleagues # Internal Medicine # Urology # Family Practice # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 13 December at 03.33 PM Increasing Body Mass Index Tied to 18 Site-Specific Cancers in Men Increasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer ( # Pediatrics # Gastroenterology # Internal Medicine # Urology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 01 December at 05.02 PM MRI Measure May ID Men at Risk for Postradiation Genitourinary Toxicity Longer prostatic urethral length measured on prostate magnetic resonance imaging (MRI) is independently associated with a higher risk for developing late genitourinary (GU) toxicity after radiation therapy (RT) for prostate cancer, according to a study published online Oct. 17 in Academic Radiology.Joseph Lee, M.D., Ph.D., from the # Urology # Hematology & Oncology # Radiology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

HealthDay 06 November at 04.58 PM Black Men More Likely Than Whites to Have Prostate Cancer at Any Given PSA Level At any given prostate-specific antigen (PSA) level, Black men are more likely than White men to develop prostate cancer, according to a study published online Nov. 6 in Cancer.Kyung Min Lee, Ph.D., from the VA Salt Lake City Health Care System, and colleagues predicted the likelihood of prostate cancer diagnosis on first biopsy for 75,29 # Internal Medicine # Urology # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn


Medical xPress 05 July at 07.10 AM When it comes to male life expectancy, nature and nurture work together Although the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 05 July at 06.50 AM Study explores the link between stock market fluctuations and emergency room visits in China The advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 30 June at 07.40 AM Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts say Intrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 27 June at 03.19 PM Immunoglobulin Replacement Therapy Beneficial for Blood Cancers Immunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 26 June at 04.59 PM When Was the Last Time You Really Talked With Your Patient? My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 23 June at 09.21 PM Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D ORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medpage Today 22 June at 06.00 PM Fenofibrate Slows Diabetic Retinopathy Progression ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 22 June at 06.00 PM Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic Stroke TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 22 June at 05.20 PM Lawsuit could challenge trust in Ozempic and other popular weight loss drugs The manufacturers of the most popular weight loss drugs are being challenged in court. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 21 June at 03.38 PM Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is Low The overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn